SCHEMBL10167015

SCHEMBL10167015

C#CCN(c1ccc(S(=O)(=O)c2ccccc2)cc1Cl)S(C)(=O)=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 1/20 0.38
TYMS P04818 3/20 0.37
POLB P06746 3/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
ALDH1A1 P00352 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MAPT P10636 1/20 0.37
GAA P10253 1/20 0.37
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
ESR1 P03372 2/20 0.36
LMNA P02545 2/20 0.36
HSD17B10 Q99714 1/20 0.36
PTGS2 P35354 2/20 0.35
PTGS1 P23219 1/20 0.35
PER2 O15055 1/20 0.35
HTR6 P50406 1/20 0.35
THRB P10828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10167009 0.73 TYMS (0.34) TYMSPOLBALDH1A1SMN1; SMN2MAPT
SCHEMBL10167025 0.73 HTR2A (0.36) TYMSPOLBMEN1KMT2AALDH1A1
SCHEMBL10167016 0.71 NR1H3 (0.43) POLBMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL23144699 0.69 LMNA (0.44) MEN1KMT2AALDH1A1MAPTGAA
SCHEMBL25328053 0.68 MEN1 (0.36) POLBMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL2458633 0.68 HTR6 (0.58) POLBKMT2AALDH1A1SMN1; SMN2MAPT
SCHEMBL1755239 0.67 ALDH1A1 (0.64) POLBALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL10167002 0.66 ESR1 (0.42) RORCPOLBKMT2AALDH1A1SMN1; SMN2
(Phenylsulfonyl)Benzene SCHEMBL10870153 0.65 HTR6 (0.82) POLBALDH1A1SMN1; SMN2MAPTGAA
SCHEMBL10206324 0.64 CRHBP (0.49) POLBMEN1KMT2AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8692001-B2 Sulfonamides for the modulation of PKM2 DYNAMIX PHARMACEUTICALS LTD. (IL) 2014-04-08 US disclosed
WO-2012056319-A1 SULFONAMIDES FOR THE MODULATION OF PKM2 DYNAMIX PHARMACEUTICALS LTD. (IL) 2012-05-03 WO disclosed
US-20120108631-A1 Sulfonamides for the Modulation of PKM2 DYNAMIX PHARMACEUTICALS LTD. (IL) 2012-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108631-A1 Sulfonamides for the Modulation of PKM2 PDK1, PDK4, PDK2 RORC 2722/4885TYMS 186/4885POLB 4129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.